Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIPOLAR I DISORDER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02147379
What this trial is testing

Lurasidone and Cognition in Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
University of British Columbia 53
Post-approval studies (Phase 4)UnknownNCT00335205
What this trial is testing

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Who this might be right for
Bipolar DisorderMajor Depressive Disorder
Sheba Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00150605
What this trial is testing

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Validus Pharmaceuticals 50
Post-approval studies (Phase 4)Study completedNCT00277212
What this trial is testing

A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,169
Testing effectiveness (Phase 2)Study completedNCT05064319
What this trial is testing

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Who this might be right for
Bipolar DisorderCannabis UseSchizoaffective Disorder, Bipolar Type+5 more
Medical University of South Carolina 51
Large-scale testing (Phase 3)Study completedNCT00195767
What this trial is testing

Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents

Who this might be right for
Bipolar I Disorder, Manic or Mixed
Abbott 150
Not applicableStudy completedNCT04812379
What this trial is testing

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Who this might be right for
Bipolar Disorder I
Otsuka Pharmaceutical Co., Ltd. 535
Large-scale testing (Phase 3)Study completedNCT03287869
What this trial is testing

A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.

Who this might be right for
Bipolar I DisorderAcute Mania
Otsuka Pharmaceutical Development & Commercialization, Inc. 381
Large-scale testing (Phase 3)Study completedNCT01059539
What this trial is testing

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Who this might be right for
Bipolar I Disorder
Forest Laboratories 403
Not applicableWithdrawnNCT00726154
What this trial is testing

Pilot Study of the Effects of Circadian Rhythms on the Treatment of Bipolar I Depression.

Who this might be right for
Bipolar Disorder
University of Pittsburgh
Large-scale testing (Phase 3)Study completedNCT00113594
What this trial is testing

Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder

Who this might be right for
SchizophreniaBipolar Disorder
Eli Lilly and Company 100
Large-scale testing (Phase 3)Study completedNCT00083954
What this trial is testing

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Who this might be right for
Bipolar Disorder
AstraZeneca 530
Not applicableStudy completedNCT05922956
What this trial is testing

Facial Emotion Recognition in Patients With Euthymic Bipolar Disorder I and II

Who this might be right for
Social CognitionFacial Emotion RecognitionFacial Affect+1 more
Centre Hospitalier Universitaire, Amiens 10
Not applicableStudy completedNCT05956483
What this trial is testing

Study to Assess Accuracy of Rapid Mood Screener in Adult Participants With Unipolar Major Depressive Disorder or Bipolar 1 Disorder in Real World Setting

Who this might be right for
Bipolar I Disorder
AbbVie 423
Large-scale testing (Phase 3)Study completedNCT00095511
What this trial is testing

Aripiprazole in Patients With Acute Mania

Who this might be right for
Bipolar Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 615
Not applicableUnknownNCT05420792
What this trial is testing

The Effect of Interpersonal Relationships and Social Rhythm Therapy Individuals With Bipolar Disorder

Who this might be right for
Bipolar DisorderBipolar I DisorderBipolar II Disorder
Ege University 34
Large-scale testing (Phase 3)Study completedNCT00490971
What this trial is testing

Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 768
Large-scale testing (Phase 3)Looking for participantsNCT06372964
What this trial is testing

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 384
Large-scale testing (Phase 3)Study completedNCT00606281
What this trial is testing

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 258
Large-scale testing (Phase 3)Study completedNCT00035802
What this trial is testing

Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderAffective Disorders, PsychoticMood Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 13
Next Page